Oragenics announces completion of second closing of $3.0 million preferred stock placment
Oragenics announced that it has completed the second closing contemplated by the previously disclosed securities purchase agreement with three accredited investors to purchase $3.0 million of Series A convertible preferred stock at a price of $0.25 per share . July 26, 2017